KESHAV
Informacion sobre medicamentos, indicaciones, dosis y seguridad relacionada con productos actualmente disponibles.
Calquence is a cancer medicine used in adults to treat: Calquence contains the active substance acalabrutinib.
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving…
Gilteritinib Maintenance Therapy After Transplantation in Patients With FLT3-ITD AML Who Have Measurable Residual Disease The ASCO Post
Managing post-transplant relapse in FLT3-mutated AML with gilteritinib | Rzetelska | Acta Haematologica Polonica Via Medica Journals
Up to 10 Years of Follow-Up Uphold Survival Benefit With Adjuvant Dabrafenib/Trametinib in Stage III Melanoma OncLive
Retsevmo is a cancer medicine for use in patients whose cancer is caused by certain changes in a gene called RET, leading to the production of abnormal RET proteins.
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 17, Status: Authorised
